Refresh

Ajanta Pharma Ltd. - Research Center

532331 AJANTPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23

Sales

926.07 1,085.29 945.18 1,014.58 848.86

Operating profit

227.15 327.18 273.65 276.90 144.53

Interest

1.42 2.36 2.27 0.75 1.21

Gross profit

259.41 338.55 323.54 307.61 180.07

EPS (Rs)

12.88 17.42 16.81 16.78 9.28
Quarterly  results in details
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23

Other income

33.68 13.73 52.16 31.46 36.75

Stock adjustment

-59.42 31.01 -28.16 34.40 -6.03

Raw material

259.03 239.04 223.55 217.81 231.89

Power and fuel

- - - - -

Employee expenses

215.97 216.41 205.48 196.30 207.06

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

283.34 271.65 270.66 289.17 271.41

Provisions made

- - - - -

Depreciation

33.47 33.41 33.04 32.24 32.11

Taxation

63.25 84.99 78.14 63.33 30.75

Net profit / loss

162.69 220.15 212.36 212.04 117.21

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

25.27 25.27 25.27 25.27 25.27

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

24.53 30.15 28.95 27.29 17.03

GPM (%)

27.03 30.80 32.44 29.41 20.33

NPM (%)

16.95 20.03 21.29 20.27 13.23
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com